🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ESMO 2020 - a whole session on stage III melanoma and surgery/aduvant/neoadjuvant therapy

Very important paper addressing what to do after adjuvant therapy led by Dr Bhave: ‚Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis’ in British Journal of Cancer. Ihttps://www.nature.com/articles/s41416-020-01121-y.

For all interested in personalized neoadjuvant immunotherapy - our perspectives article available in open access: Versluis JM, Thommen DS, Blank CU Rationalizing the pathway to personalized neoadjuvant immunotherapy: the Lombard Street Approach, JITC jitc.bmj.com/content/jitc/8…

our SARS-CoV2 paper is now as preprint online biorxiv.org/cgi/content/sh…

Internist-oncoloog Christian Blank is benoemd tot Leidse bijzonder hoogleraar Interne Geneeskunde, in het bijzonder klinisch onderzoek van #immunotherapie van #kanker. ➡️ bit.ly/3m6GzV6

Proud to be named a Highly Cited Researcher 2020 for significant influence in Cross-Field through publication of multiple papers, highly cited by my peers, over the last decade. See the full list of #HighlyCitedResearchers 2020 recognition.webofscience.com/awards/highly-…

New #JITC article: Comprehensive analysis of cutaneous and uveal melanoma liver metastases Christian Blank ow.ly/tQHK50CCUPo

EMA organises public meeting on COVID-19 vaccines | European Medicines Agency europa.eu/!CG98CQ via EU Medicines Agency

our updated data from neoadjuvant immunotherapy are available: rdcu.be/ceX3g

Congrats Monique and coauthors to this important work showing that checkpoint inhibitor therapy is possible for patients with autoimmune disease r.mail.acpnews.org/tr/cl/NTFW9y1M…

Georgina‘s breakfast radio interview on the INMC pooled paper on neoadjuvant trials in melanoma abc.net.au/radionational/…

esmo.org/oncology-news/…

AddThis | Home authors.elsevier.com/a/1ckl~3QE--Nh… another milestone paper showing that amputation from primary melanoma can be prevented bij neoadjuvant immunotherapy

AddThis | Home authors.elsevier.com/c/1d2y35EIIgEB…

important paper addressing what to do after progressing upon anti-PD1

NADINA studie in spotlight bij Stichting Melanoom (p29-33) …1-425d-ac46-cb2e50e167f1.filesusr.com/ugd/5b06c6_1dc…

At ESMO 2021 we have presented the first data from DONIMI - a study testing personalized neoadjuvant immunotherapy in melanoma

congresmailingoncologie.nl/ESMO-2021/podc…

Ik kom in actie voor kankeronderzoek en doe mee met Swim to Fight Cancer | Haarlem 2022. Steun je mij? Elke euro telt. fightcancer.nl/s/16273/18972/t